BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+12.44%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.87B
AUM Growth
+$7.87B
(+11%)
Cap. Flow
+$193M
Cap. Flow
% of AUM
2.46%
Top 10 Holdings %
Top 10 Hldgs %
73.35%
Holding
115
New
19
Increased
20
Reduced
44
Closed
6
Top Buys
| 1 |
ITMN
INTERMUNE INC
ITMN
|
$140M |
| 2 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$37.9M |
| 3 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$31.1M |
| 4 |
Heron Therapeutics
HRTX
|
$30.2M |
| 5 |
XNPT
XENOPORT, INC.
XNPT
|
$15.5M |
Top Sells
| 1 |
Arrowhead Research
ARWR
|
$38.7M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$35.1M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$25.4M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$8.81M |
| 5 |
Halozyme
HALO
|
$7.61M |
Sector Composition
| 1 | Healthcare | 43.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
51
DELISTED
Zogenix, Inc.
ZGNX
| $6.69M | 0.09% |
2,350,400
-400,600
| -15% | -$1.14M |
|
|
ACGN
52
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $6.58M | 0.08% |
1,613,076
-1,558,689
| -49% | -$6.36M |
|
53
Xencor
XNCR
$594M
| $6.36M | 0.08% |
542,363
-7,637
| -1% | -$89.6K |
|
|
AERI
54
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $6.34M | 0.08% |
299,356
-644
| -0.2% | -$13.6K |
|
55
Novavax
NVAX
$1.2B
| $5.54M | 0.07% |
1,223,362
-63,551
| -5% | -$288K |
|
56
Ironwood Pharmaceuticals
IRWD
$201M
| $5.5M | 0.07% |
446,160
-100,000
| -18% | -$1.23M |
|
|
TBRA
57
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $5.01M | 0.06% |
+400,000
| New | +$5.01M |
|
58
Ligand Pharmaceuticals
LGND
$3.25B
| $4.94M | 0.06% |
73,400
| – | – |
|
59
Ultragenyx Pharmaceutical
RARE
$3.04B
| $4.89M | 0.06% |
+100,000
| New | +$4.89M |
|
|
EPZM
60
DELISTED
Epizyme, Inc
EPZM
| $4.87M | 0.06% |
214,012
-5,988
| -3% | -$136K |
|
|
OSIR
61
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $4.75M | 0.06% |
361,530
-13,752
| -4% | -$181K |
|
|
RXDX
62
DELISTED
Ignyta, Inc.
RXDX
| $4.74M | 0.06% |
+571,000
| New | +$4.74M |
|
|
PTLA
63
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.73M | 0.06% |
182,591
-41,843
| -19% | -$1.08M |
|
|
BLUE
64
DELISTED
bluebird bio
BLUE
| $4.51M | 0.06% |
198,260
+83,799
| +73% | +$1.91M |
|
|
AKTX
65
Akari Therapeutics
AKTX
$21.4M
| $4.37M | 0.06% |
+673,887
| New | +$4.37M |
|
66
Travere Therapeutics
TVTX
$1.75B
| $4.19M | 0.05% |
+197,178
| New | +$4.19M |
|
67
Ionis Pharmaceuticals
IONS
$9.64B
| $4.16M | 0.05% |
96,303
-150,733
| -61% | -$6.51M |
|
|
BDSI
68
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3.55M | 0.05% |
421,005
-425,000
| -50% | -$3.59M |
|
|
FURX
69
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $3.51M | 0.04% |
+40,309
| New | +$3.51M |
|
70
Enanta Pharmaceuticals
ENTA
$189M
| $3.24M | 0.04% |
80,957
-28,140
| -26% | -$1.13M |
|
71
MacroGenics
MGNX
$121M
| $2.68M | 0.03% |
96,165
-3,835
| -4% | -$107K |
|
|
LJPC
72
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.39M | 0.03% |
+221,631
| New | +$2.39M |
|
73
Madrigal Pharmaceuticals
MDGL
$9.7B
| $2.16M | 0.03% |
500,000
| – | – |
|
74
Savara
SVRA
$591M
| $2.04M | 0.03% |
+3,000,000
| New | +$2.04M |
|
75
OraSure Technologies
OSUR
$230M
| $1.87M | 0.02% |
234,664
-8,803
| -4% | -$70.2K |
|